Literature DB >> 15709121

Cerebral hyperperfusion following carotid endarterectomy: diagnostic utility of intraoperative transcranial Doppler ultrasonography compared with single-photon emission computed tomography study.

Kuniaki Ogasawara1, Takashi Inoue, Masakazu Kobayashi, Hidehoko Endo, Kenji Yoshida, Takeshi Fukuda, Kazunori Terasaki, Akira Ogawa.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral hyperperfusion syndrome is a rare but serious complication of carotid endarterectomy (CEA). The aim of the present study was to determine whether intraoperative blood flow velocity (BFV) monitoring in the middle cerebral artery (MCA) by using transcranial Doppler ultrasonography (TCD) could be used as a reliable technique to detect cerebral hyperperfusion following CEA by comparing findings with those of brain single photon emission CT (SPECT).
METHODS: Intraoperative BFV monitoring was attempted in 67 patients undergoing CEA for treatment of ipsilateral internal carotid artery (ICA) stenosis (> or =70%). Cerebral blood flow (CBF) was also assessed using SPECT, which was performed before and immediately after CEA.
RESULTS: Intraoperative BFV monitoring was achieved in 60 patients. Of the 60 patients, post-CEA hyperperfusion (CBF increase > or =100%, compared with preoperative values) was observed in six patients. The sensitivity, specificity, and positive predictive value of the BFV increases immediately after declamping of the ICA for detecting post-CEA hyperperfusion was 100%, 94% and 67%, respectively, with a cut-off point 2.0-fold that of preclamping BFV. The sensitivity and specificity of the BFV increases at the end of the procedure for detecting post-CEA hyperperfusion were 100% for both parameters, with cut-off points of 2.0- to 2.2-fold BFV of preclamping value. Hyperperfusion syndrome developed in two patients with post-CEA hyperperfusion, but intracerebral hemorrhage did not occur. In one of these two patients, BFV monitoring was not possible because of failure to obtain an adequate bone window.
CONCLUSION: Intraoperative MCA BFV monitoring by using TCD is a less reliable method to detect cerebral hyperperfusion following CEA than postoperative MCA BFV monitoring, provided adequate monitoring can be achieved.

Entities:  

Mesh:

Year:  2005        PMID: 15709121      PMCID: PMC7974091     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  24 in total

1.  Prediction and monitoring of cerebral hyperperfusion after carotid endarterectomy by using single-photon emission computerized tomography scanning.

Authors:  Kuniaki Ogasawara; Hirotsugu Yukawa; Masakazu Kobayashi; Chiaki Mikami; Hiromu Konno; Kazunori Terasaki; Takashi Inoue; Akira Ogawa
Journal:  J Neurosurg       Date:  2003-09       Impact factor: 5.115

2.  Intracranial hemorrhage after carotid endarterectomy.

Authors:  F B Pomposelli; P J Lamparello; T S Riles; C C Craighead; G Giangola; A M Imparato
Journal:  J Vasc Surg       Date:  1988-02       Impact factor: 4.268

3.  Three cases of hyperperfusion syndrome identified by daily transcranial Doppler investigation after carotid surgery.

Authors:  A Schaafsma; L v d Veen; J P M Vos
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-01       Impact factor: 7.069

4.  Transcranial Doppler detected cerebral microembolism following carotid endarterectomy. High microembolic signal loads predict postoperative cerebral ischaemia.

Authors:  C R Levi; H M O'Malley; G Fell; A K Roberts; M C Hoare; J P Royle; A Chan; B C Beiles; B R Chambers; C F Bladin; G A Donnan
Journal:  Brain       Date:  1997-04       Impact factor: 13.501

5.  An observational study of pre-operative transcranial Doppler examinations to predict cerebral hyperperfusion following carotid endarterectomies.

Authors:  R Keunen; H W Nijmeijer; D Tavy; K Stam; R Edelenbosch; E Muskens; C Bruijninckx; H Sier
Journal:  Neurol Res       Date:  2001-09       Impact factor: 2.448

6.  Transcranial Doppler monitoring during carotid endarterectomy helps to identify patients at risk of postoperative hyperperfusion.

Authors:  J E Dalman; I C Beenakkers; F L Moll; J A Leusink; R G Ackerstaff
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-09       Impact factor: 7.069

7.  Incidence and etiology of intracerebral hemorrhage following carotid endarterectomy.

Authors:  R A Solomon; C M Loftus; D O Quest; J W Correll
Journal:  J Neurosurg       Date:  1986-01       Impact factor: 5.115

8.  Intracerebral haemorrhage after carotid endarterectomy.

Authors:  T Schroeder; H Sillesen; J Boesen; H Laursen; P Sørensen
Journal:  Eur J Vasc Surg       Date:  1987-02

9.  Transcranial regional cerebral oxygen saturation monitoring during carotid endarterectomy as a predictor of postoperative hyperperfusion.

Authors:  Kuniaki Ogasawara; Hiromu Konno; Hirotsugu Yukawa; Hidehiko Endo; Takashi Inoue; Akira Ogawa
Journal:  Neurosurgery       Date:  2003-08       Impact factor: 4.654

10.  Quantitative mapping of regional cerebral blood flow using iodine-123-IMP and SPECT.

Authors:  H Iida; H Itoh; M Nakazawa; J Hatazawa; H Nishimura; Y Onishi; K Uemura
Journal:  J Nucl Med       Date:  1994-12       Impact factor: 10.057

View more
  11 in total

1.  Blood-brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome.

Authors:  Sebastian Ivens; Szendro Gabriel; George Greenberg; Alon Friedman; Ilan Shelef
Journal:  J Neurol       Date:  2009-11-22       Impact factor: 4.849

2.  Sentinel Angiographic Signs of Cerebral Hyperperfusion after Angioplasty and Stenting of Intracranial Atherosclerotic Stenosis: A Technical Note.

Authors:  M Ghuman; A C O Tsang; J M Klostranec; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2019-07-25       Impact factor: 3.825

3.  Changes in chorioretinal blood flow velocity and cerebral blood flow after carotid endarterectomy.

Authors:  Hiroshi Enaida; Shinji Nagata; Atsunobu Takeda; Shintaro Nakao; Yasuhiro Ikeda; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2016-08-26       Impact factor: 2.447

4.  Evaluation of Cerebral Hyperperfusion After Carotid Artery Stenting Using C‑Arm CT Measurements of Cerebral Blood Volume.

Authors:  Michio Fujimoto; Hiroshi Itokawa; Masao Moriya; Noriyoshi Okamoto; Jinichi Sasanuma
Journal:  Clin Neuroradiol       Date:  2016-12-11       Impact factor: 3.649

5.  Isolated Subarachnoidal Hemorrhage following Carotid Endarterectomy.

Authors:  Marie Bodenant; Didier Leys; Christian Lucas
Journal:  Case Rep Neurol       Date:  2010-06-08

6.  A new rodent model of cerebral hyperperfusion.

Authors:  Bin Jia; Lei Zhao; Wei Xiao; Bing Cai; Tian-Long Wang; Dong-Guo Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

7.  The safety and efficacy of staged angioplasty for treating carotid stenosis with a high risk of hyperperfusion: A single-center retrospective study.

Authors:  Yue Wan; Hui Wang; Dapeng Wang; Hao Tian; Jing Zuo; Qi Fang
Journal:  Interv Neuroradiol       Date:  2020-08-09       Impact factor: 1.610

8.  Prediction of Cerebral Hyperperfusion Syndrome with Velocity Blood Pressure Index.

Authors:  Zhi-Chao Lai; Bao Liu; Yu Chen; Leng Ni; Chang-Wei Liu
Journal:  Chin Med J (Engl)       Date:  2015-06-20       Impact factor: 2.628

9.  Staged carotid artery angioplasty and stenting for patients with high-grade carotid stenosis with high risk of developing hyperperfusion injury: a retrospective analysis of 44 cases.

Authors:  Dapeng Mo; Gang Luo; Bo Wang; Ning Ma; Feng Gao; Xuan Sun; Xiaotong Xu; Zhongrong Miao
Journal:  Stroke Vasc Neurol       Date:  2016-12-19

10.  Cerebral Hyperperfusion after Revascularization Inhibits Development of Cerebral Ischemic Lesions Due to Artery-to-Artery Emboli during Carotid Exposure in Endarterectomy for Patients with Preoperative Cerebral Hemodynamic Insufficiency: Revisiting the "Impaired Clearance of Emboli" Concept.

Authors:  Kentaro Fujimoto; Yoshiyasu Matsumoto; Kohki Oikawa; Jun-Ichi Nomura; Yasuyoshi Shimada; Shunrou Fujiwara; Kazunori Terasaki; Masakazu Kobayashi; Kenji Yoshida; Kuniaki Ogasawara
Journal:  Int J Mol Sci       Date:  2016-08-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.